| Title： | Chinese expert consensus on off-label drug list (Pediatrics 2024 version) |
| Edition： | Updated |
| Classification： | Experts consensus |
| Field： | Treatment |
| Countries and regions： | China |
| Guidelines users： | 医生、护士、药师 |
| Evidence classification method： | The Thomson classification system standard of Micromedex and reference to other authoritative guidelines and consensus grading standards |
| Development unit： | Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University、Shenzhen Children's Hospital、Hospital Pharmacy Committee of Guangdong Pharmaceutical Society、 Pediatric Clinical Rational Drug Use Expert Committee of Guangdong Pharmaceutical Society |
| Registration time: | 2024-09-03 |
| Registration number： | PREPARE-2024CN389 |
| Purpose of the guideline: | The management of pediatric off-label drug use is an important issue faced by all hospitals. In order to assist all medical institutions to develop the catalog of pediatric off-label drug use for reference of all medical institutions. |
Latest registration
